Article Details

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Receives Consensus Recommendation of "Buy ...

Retrieved on: 2021-01-06 08:03:53

Tags for this article:

Click the tags to see associated articles and topics

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Receives Consensus Recommendation of "Buy .... View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 59,744 shares of the biopharmaceutical company's stock valued at $1,075,000 after buying an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo